SCHEMBL4564604

SCHEMBL4564604

C=CCN(CC=C)c1ccc(C(C)=O)cc1

nearest known ligand 0.50

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
MAPT P10636 4/20 0.50
KMT2A Q03164 2/20 0.50
MEN1 O00255 1/20 0.50
POLB P06746 1/20 0.50
GAA P10253 1/20 0.50
MCL1 Q07820 1/20 0.50
NOX1 Q9Y5S8 1/20 0.50
RAB9A P51151 3/20 0.47
KDM4E B2RXH2 1/20 0.47
NPC1 O15118 1/20 0.47
MAPK1 P28482 1/20 0.47
SMN1; SMN2 Q16637 1/20 0.46
PTPN1 P18031 2/20 0.44
TSHR P16473 1/20 0.40
HPGD P15428 3/20 0.39
LMNA P02545 2/20 0.39
L3MBTL1 Q9Y468 2/20 0.39
ALDH1A1 P00352 1/20 0.39
HSD17B1 P14061 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10061935 0.91 MAPT (0.58) MAPTKMT2AMEN1POLBGAA
SCHEMBL9321439 0.86 SMN1; SMN2 (0.43) MAPTKMT2AMEN1POLBGAA
SCHEMBL88637 0.85 HPGD (0.52) MAPTRAB9ANPC1SMN1; SMN2PTPN1
SCHEMBL609106 0.83 SMN1; SMN2 (0.40) MAPTKMT2AMEN1POLBGAA
SCHEMBL250420 0.83 TSHR (0.46) KMT2AMEN1POLBRAB9ANPC1
SCHEMBL5950655 0.81 KDM4E (0.47) MAPTKMT2APOLBGAARAB9A
SCHEMBL9320624 0.80 HDAC3 (0.42) MAPTRAB9AKDM4ESMN1; SMN2PTPN1
SCHEMBL851567 0.79 CHKA (0.50) GAAMAPK1SMN1; SMN2PTPN1TSHR
SCHEMBL1521415 0.79 RAB9A (0.58) MAPTKMT2AMEN1RAB9ANPC1
SCHEMBL7854278 0.79 MEN1 (0.47) MAPTKMT2AMEN1GAARAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-111620839-B Preparation method for synthesizing phenyl pyrrolidine derivative in series under metal catalysis 威海海洋生物医药产业技术研究院有限公司 2022-09-16 CN disclosed
US-7572938-B2 Precursors for ketones and aldehydes GIVAUDAN SA (CH) 2009-08-11 US disclosed
EP-1467981-A1 4(HETERO-) ARYL SUBSTITUTED (THIA-/OXA-/PYRA) ZOLES FOR INHIBITION OF TIE-2 Kylix Pharmaceuticals B.V. (NL) 2004-10-20 EP disclosed
US-20040171516-A1 Precursors for ketones and aldehydes GIVAUDAN SA (CH) 2004-09-02 US disclosed
WO-2003062215-A1 4(HETERO-) ARYL SUBSTITUTED (THIA-/OXA-/PYRA) ZOLES FOR INHIBITION OF TIE-2 KYLIX PHARMACEUTICALS B.V. (NL) 2003-07-31 WO disclosed
EP-1262473-A1 Precursors for fragrant ketones and fragrant aldehydes Givaudan SA (CH) 2002-12-04 EP disclosed
US-5912061-A UV-ray setting resin and a method for manufacturing a magneto-optical disk by the use of the UV-ray setting resin MATSUSHITA ELECTRIC INDUSTRIAL CO., LTD. (JP) 1999-06-15 US disclosed
US-5185363-A Administering for treatment of inflammatory diseases ABBOTT LABORATORIES (US) 1993-02-09 US disclosed
US-4754047-A ANIMAL GROWTH REGULATORS AMERICAN CYANAMID COMPANY (US) 1988-06-28 US disclosed
US-4522822-A Phenylethane derivatives and acid addition salts thereof for increasing lean meat deposition and/or improving lean meat to fat ratio in warm blooded animals AMERICAN CYANAMID COMPANY (US) 1985-06-11 US disclosed
US-4501751-A Phenylethanolamine derivatives and acid addition salts thereof for enhancing the growth rate of meat-producing animals and improving the efficiency of feed utilization thereby AMERICAN CYANAMID COMPANY (US) 1985-02-26 US disclosed
US-4407819-A ANIMAL GROWTH REGULATORS AMERICAN CYANAMID COMPANY (US) 1983-10-04 US disclosed
US-4404222-A Phenylethanolamine derivatives and acid addition salts thereof for enhancing the growth rate of meat-producing animals and improving the efficiency of feed utilization thereby AMERICAN CYANAMID COMPANY (US) 1983-09-13 US disclosed
EP-0049728-A2 Method for enhancing the growth rate of meat-producing animals and for improving the lean meat to fat ratio thereof AMERICAN CYANAMID COMPANY (US) 1982-04-21 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040171516-A1 Precursors for ketones and aldehydes PDK3, PDK4, AKR1C4 MAPT 3633/4885KMT2A 2984/4885MEN1 3742/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.